Outcomes	Groups n[%]
Outcomes	Total	Infection No Surgery	Infection Pos Surgery	Ischemic DFU	DFU No Infection	Charcot foot	Leg ulcer	p
Gender
Female	68 [31,19]	26 [28,89]	16[24,62]	8[40,00]	8[33,33]	5[35,71]	5[62,50]	0,312*
Male	150 [68,87]	61 [70,11]	49[75,38]	12[60,00]	16[66,67]	9[64,29]	3[37,50]
Wagner grade
1	6 [2,75]	0 [0,00]	0[0,00]	0[0,00]	5[20,83]	0[0,00]	1[12,50]	<0,001*
2	28 [12,84]	1 [1,15]	0[0,00]	0[0,00]	19[79,17]	6[42,86]	2[25,00]
3	161 [73,85]	84 [96,55]	65[100,00]	0[0,00]	0[0,00]	8[57,14]	4[50,00]
4	23 [10,55]	2 [2,30]	0[0,00]	20[100,00]	0[0,00]	0[0,00]	1[12,50]
Peripheral Arterial Disease Classification
PAD 1	161 [73.85 ]	73 [83.91]	53[81.54]	0[0.00]	17[70.83]	13[92.86]	5[62.50]	<0,001*
PAD 2	57 [26.15 ]	14 [16.09]	12[18.46]	20[100.00]	7[29.17]	1[7.14]	3[37.50]
Neuropathy
No	17 [7,83]	1 [1,15]	7[10,77]	3[15,00]	2[8,70]	0[0,00]	4[50,00]	<0,001*
Yes	200 [92,17]	86 [98,85]	58[89,23]	17[85,00]	21[91,30]	14[100,00]	4[50,00]
PA****
No	124 [56.88 ]	62 [71.26]	20[30.77]	14[70.00]	12[50.00]	10[71.43]	6[75.0]	<0,001*
Yes	94 [43.12 ]	25 [28.74]	45[69.23]	6[30.00]	12[50.00]	4[28.57]	2[25.0]
Insulin use
No	91 [41,74]	32 [36,78]	39[60,00]	9[45,00]	5[20,83]	5[35,71]	1[12,50]	0,004*
Yes	127[58,26]	55 [63,22]	26[40,00]	11[55,00]	19[79,17]	9[64,29]	7[87,50]
Quantitative measures
RS Score median	6	3	9	16	4	6	12	<0,001**
Time (weeks) median	16	13	21,9	8	17,1	40,7	23,2	<0,001**
Average age	59	59,4	57,4	60,3	59,3	62,1	59,9	0,540***

Table 1:

*Chi-square, **Kruskal-Wallis, ***ANOVA, ****PA is previous amputation

Outcomes	Groups
Outcomes	Total	Infection No Surgery	Infection Pos Surgery	Ischemic DFU	DFU No Infection	Charcot foot	Leg ulcer	p
Time of disease diabetes (median of years)	15	16	13.44	19	17.86	15.25	9.85	0.086*
insulin use %	58.26	63.21	40	55	79.16	64.28	87.5	0.004**
PAD %	26.15	16.09	16.92	100	29.16	7.14	37.5	<0.001**
Previous amputations %	15.6	28.73	69.23	30	50	28.57	25	<0.001**
Risk score (Median of Tardivo Algor)	6	5	9	16	5	8	***	<0.001*
Salvage %	84.4	86.2	93.84	20	100	92.85	87.58	<0.001**
Sessions until outcome (n)	10	12	18	6	9	19.42	13	<0.001*
Treatment time (median of weeks)	6	16.9	28.03	_	19.1	51.73	28.82	<0.001*